Youth Futures supports at-risk and homeless Utah children
With overnight shelter, drop-in services and street outreach, Mitchell says the Youth Futures organization has changed countless lives and helped to lessen the cycle of homelessness at no cost to the kids.
As founder, Mitchell's involvement began one winter night while working on a mental health hotline for youth. During a conversation with a young boy, she found her new calling.
'He was in a park and wouldn't tell me where he was, but he was feeling suicidal, had no place to go and was very distraught,' Mitchell recalled. 'I talked to him on the phone for hours. … I stayed awake the rest of the night. When my husband woke up, I told him the story and said, 'If someone is going to do us, it's going to be us.''
Mitchell immediately got to work developing a homeless youth shelter for kids ages 12-18 and transitional living for those 16-22. In 2015, she opened her first shelter in Ogden. Since then, Youth Futures has opened shelters and transitional living centers in St. George and Cedar City. One of the most important guiding principles of the organization was never turning youth away.
Youth Futures is open 24/7 and provides access to laundry, computer access, overnight shelter, support groups, art therapy, pregnancy prevention and a myriad of other courses.
'If you can think about it, we offer it. If we don't offer it, and a kid needs it, we will figure out how to help build it,' Mitchell said.
Youth Futures is made possible by grants, fundraisers, donations and the annual Sleep Out event. The event has attendees sleep outside to raise money and ensure that youth will not have to be on the streets. Other sponsors include Havenwood Academy, a girls' trauma treatment facility that consistently donates and brings girls to help with yard work at the facility.
With all the life-changing work that happens within Youth Futures, one of the biggest obstacles has been altering the public's perception of the youth.
'There is a lot of stigma that goes on with homeless kids,' Mitchell confessed. 'They get marked as runaways or difficult kids. That is really not what these kids are dealing with. These kids are homeless and unaccompanied for reasons that are not their own.'
The stories of what led the youth to homelessness have been heartbreaking to Mitchell and only resolved her drive to help in whatever way she can. However, there is light at the end of the tunnel for the organization.
'Statistics show that kids are four times more likely to become homeless adults if they become homeless as a kid. If we can intervene early and help these kids build the life skills and resiliency that they need, they will be more likely to be successful and stay out of homelessness,' Mitchell explained.
Over the past 10 years, 80% of the youth served by Youth Futures have not entered the adult homeless system, according to Mitchell. The staggering statistics prove to Mitchell and her army of volunteers and employees that they are making a difference.
With many youth-facing programs constantly being rolled out, Youth Futures sets itself apart by consistently providing positive programs.
'Our motto is 'We serve kids no matter what.' We check our judgment at our door and meet the kids where they are at,' Mitchell explained. 'We are very youth-centered. When a kid sets their goals, it is their goals, not our suggestions of goals. We will help them down whatever path they choose. We run on positive youth development.'
For more information or to volunteer with Youth Futures, visit its website.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNBC
3 days ago
- CNBC
Healthy Returns: Researchers move closer to a universal cancer vaccine
A universal cancer vaccine – what once seemed like a pipe dream – may be inching closer to becoming reality. On Friday, University of Florida researchers said findings from a new study could lead to the development of a universal shot that can jumpstart the immune system to fight cancer. The study in mice, published in Nature Biomedical Engineering, showed that an experimental mRNA vaccine boosted the tumor-fighting effects of a common cancer drug called immune checkpoint inhibitors. The vaccine is not designed for a specific virus or cancer cells, but engineered to "wake up" the immune system against the disease, "spurring it to respond as if fighting a virus," according to a UF release. "What we found is by using a vaccine designed not to target cancer specifically but rather to stimulate a strong immunologic response, we could elicit a very strong anticancer reaction," Dr. Duane Mitchell, a co-author of the study and professor of neurosurgery at the university's College of Medicine, said in the release. That's unlike current approaches to cancer vaccines, which involve finding a target expressed by many cancer patients or, in the case of Moderna and Merck, developing personalized vaccines tailored to each patient's specific tumor. The universal vaccine has the potential to be used broadly across cancer patients, "even possibly leading us to an off-the-shelf cancer vaccine," Mitchell said. The UF researchers are still working to replicate the findings in humans. If they do, a one-size-fits-all vaccine could provide an alternative to surgery, radiation and chemotherapy. Here's how the vaccine works: The mRNA shot essentially tells the body to produce certain proteins that stimulate the immune system, including one called PD-L1, which is often found on the surface or inside of cancer cells. Those cells often use PD-L1 to hide from immune attacks. But by boosting PD-L1, the vaccine can actually make tumors more vulnerable to immune checkpoint inhibitors that block that protein, helping the immune system recognize and destroy the cancer. The study showed promising results on treatment-resistant tumors in skin cancers by combining the mRNA vaccine with a monoclonal antibody, a common immunotherapy drug that attempts to alert the immune system that a tumor is foreign and should be attacked. It also showed positive results when tested on mouse skin, bone and brain cancers as a solo treatment. In some cases, the tumors were eliminated entirely. "This paper describes a very unexpected and exciting observation: that even a vaccine not specific to any particular tumor or virus – so long as it is an mRNA vaccine – could lead to tumor-specific effects," said senior author Dr. Elias Sayour, a UF Health pediatric oncologist, in a release. Feel free to send any tips, suggestions, story ideas and data to Annika at We're just days away from the peak of digital health earnings season, and this quarter is sure to be an interesting one. The two companies that went public earlier this year, Hinge Health and Omada Health, will report results for the first time since their debut. And since President Donald Trump's tax-and-spending bill passed and his Aug. 1 tariff deadline is approaching, we'll get some insight into how digital health companies have been operating against a volatile macroeconomic and policy backdrop. Here are some of the reports CNBC will be watching for: Hinge Health – Aug. 5 Omada Health – Aug. 7 Hims & Hers Health – Aug. 4 Doximity – Aug. 7 Teladoc Health – July 29 We'll have plenty to dive into in the coming weeks, so be sure to keep up with CNBC's coverage. Feel free to send any tips, suggestions, story ideas and data to Ashley at

Yahoo
4 days ago
- Yahoo
Sarepta falls after gene therapy maker pauses Elevidys shipments in US
(Reuters) -Shares of Sarepta Therapeutics fell nearly 7% on Tuesday after the company agreed to comply with the U.S. health regulator's request to pause all shipments of its gene therapy Elevidys in the United States. The U.S. Food and Drug Administration on Friday asked Sarepta to voluntarily halt shipments of the gene therapy, but the company refused to do so and said it would continue making the treatment available to ambulatory patients. But Sarepta has now voluntarily and temporarily paused all shipments of the therapy, effective end of Tuesday. The company said the decision would allow it to respond to requests from the FDA and maintain a positive relationship with the agency. "Though Sarepta claims its pause in shipments was voluntary, we think the company moved preemptively — bracing for an inevitable FDA mandate to pull the drug," said H.C. Wainwright analyst Mitchell Kapoor. Shares of Sarepta fell 6.9% to $12.40 in early trading on Tuesday. "Sarepta's decision to comply was a capitulation after recognizing that the fight with the FDA was not winnable and that the agency would have strong-armed Sarepta into removing Elevidys with a formal demand," Kapoor added. Investor concerns regarding the use of the company's treatments have been heightened after the company on Friday disclosed that another patient who had received its experimental gene therapy died from acute liver failure, marking the third death this year. The company's shares have plummeted 89% so far this year. On Monday, Children's Hospital Los Angeles said it had paused usage of Elevidys in all patients with muscular dystrophy. The FDA's initial request had likely heightened the pressure on physicians to pause treatments, which could also have been a driving factor in Sarepta's decision, William Blair analyst Sami Corwin said. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 days ago
- Yahoo
2-Year-Old 'Miracle Boy' Dies Following Dental Surgery Complications, Family Says
Er'mias Mitchell's father said his son was healthy before going into the surgery on July 17NEED TO KNOW A toddler has died after experiencing complications during a dental surgery in North Carolina Er'mias Mitchell was allegedly transported to a local hospital without his parents present, and died before they could reach him The North Carolina Dental Board has said it will "fully investigate" the incident, which they said occurred at the "independently accredited surgery center"A 2-year-old boy has died after experiencing complications during a dental surgery. Er'mias Mitchell went into the surgery at Valleygate Dental Surgery Center in Greensboro, N.C., on the morning of Thursday, July 17, according to NBC affiliates WRAL and CBS affiliate WBTV. "He was all good this morning, nothing was wrong," David Mitchell, Er'mias's dad, told WRAL. A short time after he went into surgery, nurses allegedly came out and told his parents that the child's lung had collapsed. The parents learned about their son's condition as he was already being transported to the hospital, Spectrum News 1 reported. 'His family couldn't even be by his side when he needed us there,' David told the outlet. Er'mias had allegedly died by the time his family reached the hospital. His parents still have many questions about what happened, and David has accused the surgery center of not giving his family 'proper treatment.' 'You can't get life back, once it's gone. You can't. That was our last time. Our last time seeing him was us giving him off to them,' David told Spectrum News 1. 'He went into that room and then us seeing him in the hospital on the bed, dead.' David described Er'mias to WXII as a happy and healthy child who loved dinosaurs. He was also described in a GoFundMe campaign as 'a joyful, loving child—full of life, laughter, and endless curiosity.' Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Constance McCrae, who organized the online fundraiser, said Er'mias was David and Sharde Sherrill's only child. David described his son to WXII as 'the best child on this planet.' He also said Er'mias was his mom's 'miracle baby.' According to Spectrum News 1, Er'mias' mom was previously told she couldn't have children and experienced complications during her pregnancy. 'It's like a life is stolen from her, and we don't know what to do,' David said, per WRAL. Er'mias' family is now awaiting results from the child's autopsy, according to Spectrum News 1. In a statement, the Valleygate Dental Surgery Center said that complications during oral surgeries are rare but can occur unexpectedly. 'Our thoughts are with their family and loved ones during this unimaginably difficult time,' the statement said, according to WRAL. 'The health and well-being of every patient is our highest priority.' They continued, 'Our staff includes an array of highly experienced and board-certified physician anesthesiologists, certified registered nurse anesthetists (CRNAs), and nurses. Our professionals are dedicated to providing a caring, nurturing environment where comfort, dental health, and safety are of primary importance.' Valleygate Dental Surgery Center did not immediately respond to PEOPLE's request for comment. Additionally, the North Carolina Dental Board said in a separate statement that it will 'fully investigate the circumstances surrounding' Er'mias' death. "First, the Dental Board joins with all who mourn the death of Er'Mias Mitchell and, though strangers to his family, we are deeply saddened by this tragic news,' the board said, according to WXII. They also noted that Valleygate Dental Surgery Center 'is an independently accredited surgery center utilizing the services of both medical and dental professionals and is not licensed, certified, or accredited by the NC Dental Board.' 'Early indications are that the Dental Board's investigation will focus on whether this death occurred as a result of sedation administered by a medical provider (over which the Dental Board has no jurisdiction) or was the result of improper dental treatment which, of course, is within our jurisdiction,' the board concluded. Read the original article on People Solve the daily Crossword